Methods and compounds for treating depression and other disorders
申请人:NPS Pharmaceuticals, Inc.
公开号:US20040039014A1
公开(公告)日:2004-02-26
The present invention features compounds active at both the serotonin reuptake site and the N-methyl-D-aspartate (NMDA) receptor and the use of such compounds for treating different disorders. Compounds having activity at the serotonin reuptake site and the NMDA receptor (“multi-active compounds”) can be used to treat different types of disorders such as depression, obsessive-compulsive disorders (OCD), sleep, disorders, sexual dysfunction, and eating disorders. Preferably, the multi-active compounds are used to treat depression.
Tetrasubstituted carbon containing two different halogen substituents was constructed in a single-step operation by utilizing the carbene-like reactivity of dioxaphospholene through the tandem reaction of electrophilic and nucleophilic halogenating reagents. It was crucial to devise non-dealkylatable phosphoramidite, which enabled the efficient formation of geminal chlorofluorides from various 1,2-diketones
The photoinduced reductive dehalogenation promiscuity of cyclohexanonemonooxygenase (CHMO) with a novel mechanism of ET/PT distinct from the photoinducedpromiscuity of natural reductases is reported. Various highly enantioenriched α-fluoroketones were synthesized by photoinduced reductive dehalogenation of α,α-halofluoroketones in a process catalyzed by the rationally designed CHMO mutants.
Fluorine-Assisted Rearrangement of Geminal Azidofluorides to Imidoyl Fluorides
作者:Ha Eun Kim、Jun-Ho Choi、Won-jin Chung
DOI:10.1021/acs.joc.3c00183
日期:2023.6.2
tandem preparative method for potentially useful and bench-stable imidoyl fluorides from a wide range of structurally diverse geminal chlorofluorides. Our additional efforts to expand the reaction scope regarding the migrating group, halogen, and carbonyl function are described, and the synthetic utility of the imidoyl fluoride products was demonstrated in hopes of promoting the use of this under-appreciated